Efficacy and Safety of Canagliflozin in the Treatment of Type 2 Diabetes With Mild Cognitive Impairment
Conditions
Type 2 Diabetes Mellitus · Cognitive Impairment
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Fudan University affiliated Huadong Hospital, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Bin Lu, doctor)